Literature DB >> 17065363

Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins.

P Michal1, E E El-Fakahany, V Dolezal.   

Abstract

Muscarinic M(2) receptors preferentially couple with the G(i/o) class of G-proteins to inhibit cAMP synthesis. However, they can also stimulate net synthesis of cAMP and inositol phosphate (IP) accumulation. We investigated in intact Chinese hamster ovary (CHO) cells expressing human M(2) receptors (CHO-M(2) cells) whether direct interaction of M(2) receptors with G(s) and G(q/11) G-proteins is responsible for the latter effects. Suppression of the G(s)alpha subunit using RNA interference abolished stimulation of cAMP synthesis induced by 1 mM carbachol in both control and pertussis toxin-treated CHO-M(2) cells but had no effect on the inhibition of forskolin-stimulated cAMP synthesis. Carbachol stimulated accumulation of IP with an EC(50) of 79 microM. Removal of the G(q),G(11), or both alpha subunits reduced this response by 78, 54, and 92%, respectively, whereas suppression of the G(s)alpha subunit had no effect. Similar results obtained in CHO cells expressing M(1) receptors that preferentially couple with G(s) and G(q/11) G-proteins confirmed the efficiency of siRNA treatments. Stimulation of M(2) receptors in control and pertussis toxin-treated cells by a series of full agonists with respect to inhibition of adenylyl cyclase displayed different efficacies in stimulating IP accumulation. Carbachol, acetylcholine, and oxotremorine-M [N,N,N-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium] behaved as full agonists, furmethide (N,N,N-trimethyl-2-furanmethammonium) and methylfurmethide [(5-methyl-2-furyl)methyltrimethylammonium] were partial agonists, and oxotremorine (1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinone) had no effect. Our results provide direct evidence of M(2) receptor coupling with the alpha subunits of G(s) and G(q/11) G-proteins and demonstrate induction of multiple receptor conformational states dependent on both the concentration and the nature of the agonist used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065363     DOI: 10.1124/jpet.106.114314

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.

Authors:  Ikuo Masuho; Olga Ostrovskaya; Grant M Kramer; Christopher D Jones; Keqiang Xie; Kirill A Martemyanov
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

2.  Imaging of Tissue-Specific and Temporal Activation of GPCR Signaling Using DREADD Knock-In Mice.

Authors:  Dmitry Akhmedov; Nicholas S Kirkby; Jane A Mitchell; Rebecca Berdeaux
Journal:  Methods Mol Biol       Date:  2019

3.  Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways.

Authors:  Pavel Michal; Vladimír Rudajev; Esam E El-Fakahany; Vladimír Dolezal
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

4.  Novel M2 -selective, Gi -biased agonists of muscarinic acetylcholine receptors.

Authors:  Alena Randáková; Dominik Nelic; Dana Ungerová; Peter Nwokoye; Qiwen Su; Vladimír Doležal; Esam E El-Fakahany; John Boulos; Jan Jakubík
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

5.  N-Ethylmaleimide differentiates between the M2- and M4-autoreceptor-mediated inhibition of acetylcholine release in the mouse brain.

Authors:  Justine Etscheid; Klaus Mohr; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-21       Impact factor: 3.000

6.  Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.

Authors:  Katherine W Figueroa; Michael T Griffin; Frederick J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2008-09-29       Impact factor: 4.030

7.  Bladder urothelial cells from patients with interstitial cystitis have an increased sensitivity to carbachol.

Authors:  Gopal N Gupta; Shao-Gang Lu; Michael S Gold; Toby C Chai
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

8.  Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord.

Authors:  H-M Zhang; S-R Chen; Y-Q Cai; T E Richardson; L C Driver; G Lopez-Berestein; H-L Pan
Journal:  Neuroscience       Date:  2008-12-07       Impact factor: 3.590

9.  Mixed-integer nonlinear optimisation approach to coarse-graining biochemical networks.

Authors:  M R Maurya; S J Bornheimer; V Venkatasubramanian; S Subramaniam
Journal:  IET Syst Biol       Date:  2009-01       Impact factor: 1.615

Review 10.  On the analysis of ligand-directed signaling at G protein-coupled receptors.

Authors:  Frederick J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.